Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsFOR RX COMPOUNDINGGeneric

POLYMYXIN B SULFATE

POLYMYXIN B SULFATE

Standard Dose
100,000,000 UNITS/BOT
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview POLYMYXIN B SULFATE is listed in Drugs@FDA under application 062455 (ANDA).

Marketing status: Discontinued Active ingredient POLYMYXIN B SULFATE Form and strength POWDER;FOR RX COMPOUNDING - 100,000,000 UNITS/BOT Sponsor PADDOCK LLC Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview POLYMYXIN B SULFATE is listed in Drugs@FDA under application 062455 (ANDA). Marketing status: Discontinued Active ingredient POLYMYXIN B SULFATE Form and strength POWDER;FOR RX COMPOUNDING - 100,000,000 UNITS/BOT Sponsor PADDOCK LLC Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
POLYMYXIN B SULFATE (POLYMYXIN B SULFATE) | Drug Monograph | MedicHelpline